Effect of budesonide on the perception of induced airway narrowing in subjects with asthma

The perception of bronchoconstriction may be modulated by airway inflammation. However, the effect of inhaled corticosteroid (ICS) treatment on perception in subjects with asthma has received limited study. The aim of this study was to determine the effect of inhaled budesonide on the perception of breathlessness induced by histamine challenge. Thirty-five subjects with poorly controlled asthma were randomized to receive budesonide (1,600 or 3,200 μ g/d) for 8 wk, followed by 8 wk at 1,600 μ g/d and subsequent downtitration according to a clinical algorithm. Borg scores were recorded during histamine challenges performed at baseline and at 8, 16, 24, 48, and 72 wk. Perception was estimated as the slope of Borg/% fall FEV1. The Borg/FEV1 slope increased significantly after 8 wk of budesonide (0.09 [0.08–0.12] to 0.15 [0.11–0.19], p = 0.002), and remained increased compared with baseline values at all subsequent visits. There were no significant differences in Borg/ FEV1 slope between subjects who were and were not taking ICS at study entry. The magnitude of change in the Borg/FEV1 slope did not differ significantly between treatment groups and was not related to changes in baseline FEV1, airway hyperresponsiveness, blood eosinophils, or serum eosinophil cationic protein (ECP). We conclude that treatment with budesonide enhances the perception of airway narrowing, but the effect is unrelated to budesonide dose, or to changes in circulating eosinophil markers.